FTIR spectra of MUCG at different curing age. by Junxia Zhou (14381598)

Subjects:

Comparison of effects before and after improvement. by Junyan Wang (4738518)

Subjects:

Mediation analysis. by Vincenza Tarantino (182506)

Subjects:

Description of fitting models. by Junxia Zhou (14381598)

Subjects:

LUC in southeast Yunnan under different scenarios in 2035. by Bao Zhou (20670850)

Subjects:

Mineral composition of UFC, B, and SF. by Junxia Zhou (14381598)

Subjects:

Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. by Vincenza Tarantino (182506)

Subjects:

Distribution of ESs and hot and cold spots during the historical period. by Bao Zhou (20670850)

Subjects:

Spatial distribution of ESs. by Bao Zhou (20670850)

Subjects:

Fig 8 - by Junxia Zhou (14381598)

Subjects:

Correspondence of support for SDGs across ESs categories. by Bao Zhou (20670850)

Subjects:

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

General participant characteristics. by Josephine Grandt (21512356)

“…We identified 553 DEG between healthy controls and patients with NAFLD, 5527 DEG between healthy controls and patients with cirrhosis, and 3898 DEG in NAFLD compared with cirrhosis. …”

Posters by country and year [Top 10 countries] (Abbreviations: AU: Australia, BR: Brazil, CA: Canada, CN: China, DE: Germany, IT: Italy, JP: Japan, KR: South Korea, TW: Taiwan, US:... by Ignacio García-Espona (21395335)

Subjects: